nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP2D6—Temsirolimus—kidney cancer	0.0948	0.139	CbGbCtD
Dolasetron—CYP3A4—Everolimus—kidney cancer	0.0893	0.13	CbGbCtD
Dolasetron—CYP3A4—Temsirolimus—kidney cancer	0.0603	0.0881	CbGbCtD
Dolasetron—CYP2C9—Capecitabine—kidney cancer	0.0568	0.0831	CbGbCtD
Dolasetron—CYP2D6—Pazopanib—kidney cancer	0.0498	0.0728	CbGbCtD
Dolasetron—CYP2C9—Paclitaxel—kidney cancer	0.0356	0.052	CbGbCtD
Dolasetron—CYP2D6—Erlotinib—kidney cancer	0.0355	0.052	CbGbCtD
Dolasetron—CYP3A4—Pazopanib—kidney cancer	0.0317	0.0463	CbGbCtD
Dolasetron—CYP2C9—Sorafenib—kidney cancer	0.0316	0.0462	CbGbCtD
Dolasetron—CYP2D6—Sorafenib—kidney cancer	0.0289	0.0422	CbGbCtD
Dolasetron—CYP2D6—Vinblastine—kidney cancer	0.0285	0.0417	CbGbCtD
Dolasetron—CYP3A4—Erlotinib—kidney cancer	0.0226	0.033	CbGbCtD
Dolasetron—CYP3A4—Paclitaxel—kidney cancer	0.0207	0.0302	CbGbCtD
Dolasetron—CYP3A4—Sorafenib—kidney cancer	0.0184	0.0269	CbGbCtD
Dolasetron—CYP3A4—Vinblastine—kidney cancer	0.0181	0.0265	CbGbCtD
Dolasetron—CYP3A4—Vincristine—kidney cancer	0.0178	0.0261	CbGbCtD
Dolasetron—CYP2D6—Doxorubicin—kidney cancer	0.0175	0.0256	CbGbCtD
Dolasetron—CYP3A4—Sunitinib—kidney cancer	0.0149	0.0218	CbGbCtD
Dolasetron—CYP3A4—Doxorubicin—kidney cancer	0.0112	0.0163	CbGbCtD
Dolasetron—Hypotension—Vincristine—kidney cancer	0.00025	0.000791	CcSEcCtD
Dolasetron—Bradycardia—Capecitabine—kidney cancer	0.00025	0.000791	CcSEcCtD
Dolasetron—Thrombocytopenia—Gemcitabine—kidney cancer	0.000248	0.000786	CcSEcCtD
Dolasetron—Renal failure acute—Doxorubicin—kidney cancer	0.000248	0.000784	CcSEcCtD
Dolasetron—Feeling abnormal—Dactinomycin—kidney cancer	0.000247	0.000781	CcSEcCtD
Dolasetron—Hyperhidrosis—Gemcitabine—kidney cancer	0.000245	0.000776	CcSEcCtD
Dolasetron—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000245	0.000775	CcSEcCtD
Dolasetron—Tremor—Paclitaxel—kidney cancer	0.000244	0.000772	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000244	0.000771	CcSEcCtD
Dolasetron—Increased appetite—Doxorubicin—kidney cancer	0.000243	0.00077	CcSEcCtD
Dolasetron—Hypersensitivity—Sorafenib—kidney cancer	0.000242	0.000766	CcSEcCtD
Dolasetron—Anorexia—Gemcitabine—kidney cancer	0.000242	0.000765	CcSEcCtD
Dolasetron—Oedema peripheral—Capecitabine—kidney cancer	0.000242	0.000765	CcSEcCtD
Dolasetron—Dizziness—Erlotinib—kidney cancer	0.000241	0.000764	CcSEcCtD
Dolasetron—Ill-defined disorder—Paclitaxel—kidney cancer	0.000241	0.000764	CcSEcCtD
Dolasetron—Anaemia—Paclitaxel—kidney cancer	0.00024	0.000761	CcSEcCtD
Dolasetron—Paraesthesia—Vincristine—kidney cancer	0.00024	0.00076	CcSEcCtD
Dolasetron—Agitation—Paclitaxel—kidney cancer	0.000239	0.000757	CcSEcCtD
Dolasetron—Rash—Everolimus—kidney cancer	0.000239	0.000755	CcSEcCtD
Dolasetron—Dermatitis—Everolimus—kidney cancer	0.000238	0.000755	CcSEcCtD
Dolasetron—Headache—Vinblastine—kidney cancer	0.000238	0.000754	CcSEcCtD
Dolasetron—Angioedema—Paclitaxel—kidney cancer	0.000238	0.000753	CcSEcCtD
Dolasetron—Purpura—Doxorubicin—kidney cancer	0.000237	0.000751	CcSEcCtD
Dolasetron—Headache—Everolimus—kidney cancer	0.000237	0.000751	CcSEcCtD
Dolasetron—Hypotension—Gemcitabine—kidney cancer	0.000237	0.00075	CcSEcCtD
Dolasetron—Abdominal pain—Dactinomycin—kidney cancer	0.000237	0.000749	CcSEcCtD
Dolasetron—Body temperature increased—Dactinomycin—kidney cancer	0.000237	0.000749	CcSEcCtD
Dolasetron—Visual impairment—Capecitabine—kidney cancer	0.000236	0.000748	CcSEcCtD
Dolasetron—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000236	0.000748	CcSEcCtD
Dolasetron—Asthenia—Sorafenib—kidney cancer	0.000236	0.000746	CcSEcCtD
Dolasetron—Malaise—Paclitaxel—kidney cancer	0.000235	0.000743	CcSEcCtD
Dolasetron—Vertigo—Paclitaxel—kidney cancer	0.000234	0.00074	CcSEcCtD
Dolasetron—Syncope—Paclitaxel—kidney cancer	0.000233	0.000739	CcSEcCtD
Dolasetron—Hypersensitivity—Sunitinib—kidney cancer	0.000233	0.000737	CcSEcCtD
Dolasetron—Decreased appetite—Vincristine—kidney cancer	0.000232	0.000736	CcSEcCtD
Dolasetron—Pruritus—Sorafenib—kidney cancer	0.000232	0.000736	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000231	0.000732	CcSEcCtD
Dolasetron—Fatigue—Vincristine—kidney cancer	0.00023	0.00073	CcSEcCtD
Dolasetron—Rash—Erlotinib—kidney cancer	0.00023	0.000729	CcSEcCtD
Dolasetron—Dermatitis—Erlotinib—kidney cancer	0.00023	0.000728	CcSEcCtD
Dolasetron—Palpitations—Paclitaxel—kidney cancer	0.00023	0.000728	CcSEcCtD
Dolasetron—Headache—Erlotinib—kidney cancer	0.000229	0.000724	CcSEcCtD
Dolasetron—Tinnitus—Capecitabine—kidney cancer	0.000229	0.000724	CcSEcCtD
Dolasetron—Loss of consciousness—Paclitaxel—kidney cancer	0.000229	0.000724	CcSEcCtD
Dolasetron—Pain—Vincristine—kidney cancer	0.000229	0.000724	CcSEcCtD
Dolasetron—Constipation—Vincristine—kidney cancer	0.000229	0.000724	CcSEcCtD
Dolasetron—Paraesthesia—Gemcitabine—kidney cancer	0.000228	0.000721	CcSEcCtD
Dolasetron—Flushing—Capecitabine—kidney cancer	0.000228	0.000721	CcSEcCtD
Dolasetron—Cough—Paclitaxel—kidney cancer	0.000227	0.000719	CcSEcCtD
Dolasetron—Asthenia—Sunitinib—kidney cancer	0.000227	0.000718	CcSEcCtD
Dolasetron—Dyspnoea—Gemcitabine—kidney cancer	0.000226	0.000716	CcSEcCtD
Dolasetron—Somnolence—Gemcitabine—kidney cancer	0.000225	0.000714	CcSEcCtD
Dolasetron—Convulsion—Paclitaxel—kidney cancer	0.000225	0.000714	CcSEcCtD
Dolasetron—Diarrhoea—Sorafenib—kidney cancer	0.000225	0.000712	CcSEcCtD
Dolasetron—Hypertension—Paclitaxel—kidney cancer	0.000225	0.000711	CcSEcCtD
Dolasetron—Pruritus—Sunitinib—kidney cancer	0.000224	0.000708	CcSEcCtD
Dolasetron—Arthralgia—Paclitaxel—kidney cancer	0.000222	0.000701	CcSEcCtD
Dolasetron—Chest pain—Paclitaxel—kidney cancer	0.000222	0.000701	CcSEcCtD
Dolasetron—Myalgia—Paclitaxel—kidney cancer	0.000222	0.000701	CcSEcCtD
Dolasetron—Anxiety—Paclitaxel—kidney cancer	0.000221	0.000699	CcSEcCtD
Dolasetron—Face oedema—Doxorubicin—kidney cancer	0.000221	0.000699	CcSEcCtD
Dolasetron—Decreased appetite—Gemcitabine—kidney cancer	0.00022	0.000698	CcSEcCtD
Dolasetron—Hypersensitivity—Dactinomycin—kidney cancer	0.00022	0.000698	CcSEcCtD
Dolasetron—Chills—Capecitabine—kidney cancer	0.00022	0.000697	CcSEcCtD
Dolasetron—Arrhythmia—Capecitabine—kidney cancer	0.000219	0.000694	CcSEcCtD
Dolasetron—Discomfort—Paclitaxel—kidney cancer	0.000219	0.000693	CcSEcCtD
Dolasetron—Fatigue—Gemcitabine—kidney cancer	0.000219	0.000692	CcSEcCtD
Dolasetron—Gastrointestinal pain—Vincristine—kidney cancer	0.000219	0.000692	CcSEcCtD
Dolasetron—Cardiac arrest—Doxorubicin—kidney cancer	0.000217	0.000688	CcSEcCtD
Dolasetron—Dizziness—Sorafenib—kidney cancer	0.000217	0.000688	CcSEcCtD
Dolasetron—Constipation—Gemcitabine—kidney cancer	0.000217	0.000687	CcSEcCtD
Dolasetron—Pain—Gemcitabine—kidney cancer	0.000217	0.000687	CcSEcCtD
Dolasetron—Dry mouth—Paclitaxel—kidney cancer	0.000217	0.000686	CcSEcCtD
Dolasetron—Diarrhoea—Sunitinib—kidney cancer	0.000216	0.000685	CcSEcCtD
Dolasetron—Ataxia—Doxorubicin—kidney cancer	0.000215	0.00068	CcSEcCtD
Dolasetron—Asthenia—Dactinomycin—kidney cancer	0.000215	0.00068	CcSEcCtD
Dolasetron—Confusional state—Paclitaxel—kidney cancer	0.000214	0.000678	CcSEcCtD
Dolasetron—Dehydration—Doxorubicin—kidney cancer	0.000213	0.000673	CcSEcCtD
Dolasetron—Anaphylactic shock—Paclitaxel—kidney cancer	0.000212	0.000672	CcSEcCtD
Dolasetron—Oedema—Paclitaxel—kidney cancer	0.000212	0.000672	CcSEcCtD
Dolasetron—Body temperature increased—Vincristine—kidney cancer	0.000211	0.000669	CcSEcCtD
Dolasetron—Abdominal pain—Vincristine—kidney cancer	0.000211	0.000669	CcSEcCtD
Dolasetron—Flatulence—Capecitabine—kidney cancer	0.00021	0.000666	CcSEcCtD
Dolasetron—Dysgeusia—Capecitabine—kidney cancer	0.000209	0.000662	CcSEcCtD
Dolasetron—Dizziness—Sunitinib—kidney cancer	0.000209	0.000662	CcSEcCtD
Dolasetron—Feeling abnormal—Gemcitabine—kidney cancer	0.000209	0.000662	CcSEcCtD
Dolasetron—Shock—Paclitaxel—kidney cancer	0.000209	0.000661	CcSEcCtD
Dolasetron—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000209	0.000661	CcSEcCtD
Dolasetron—Thrombocytopenia—Paclitaxel—kidney cancer	0.000208	0.000658	CcSEcCtD
Dolasetron—Tachycardia—Paclitaxel—kidney cancer	0.000207	0.000656	CcSEcCtD
Dolasetron—Rash—Sorafenib—kidney cancer	0.000207	0.000656	CcSEcCtD
Dolasetron—Dermatitis—Sorafenib—kidney cancer	0.000207	0.000655	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000206	0.000652	CcSEcCtD
Dolasetron—Headache—Sorafenib—kidney cancer	0.000206	0.000652	CcSEcCtD
Dolasetron—Hyperhidrosis—Paclitaxel—kidney cancer	0.000205	0.00065	CcSEcCtD
Dolasetron—Diarrhoea—Dactinomycin—kidney cancer	0.000205	0.000648	CcSEcCtD
Dolasetron—Anorexia—Paclitaxel—kidney cancer	0.000202	0.000641	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000202	0.000638	CcSEcCtD
Dolasetron—Body temperature increased—Gemcitabine—kidney cancer	0.0002	0.000635	CcSEcCtD
Dolasetron—Tremor—Capecitabine—kidney cancer	0.0002	0.000633	CcSEcCtD
Dolasetron—Rash—Sunitinib—kidney cancer	0.000199	0.000631	CcSEcCtD
Dolasetron—Dermatitis—Sunitinib—kidney cancer	0.000199	0.00063	CcSEcCtD
Dolasetron—Abdominal distension—Doxorubicin—kidney cancer	0.000199	0.00063	CcSEcCtD
Dolasetron—Hypotension—Paclitaxel—kidney cancer	0.000198	0.000628	CcSEcCtD
Dolasetron—Ill-defined disorder—Capecitabine—kidney cancer	0.000198	0.000627	CcSEcCtD
Dolasetron—Headache—Sunitinib—kidney cancer	0.000198	0.000627	CcSEcCtD
Dolasetron—Anaemia—Capecitabine—kidney cancer	0.000197	0.000625	CcSEcCtD
Dolasetron—Hypersensitivity—Vincristine—kidney cancer	0.000197	0.000624	CcSEcCtD
Dolasetron—Pancreatitis—Doxorubicin—kidney cancer	0.000194	0.000613	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000193	0.000613	CcSEcCtD
Dolasetron—Malaise—Capecitabine—kidney cancer	0.000193	0.00061	CcSEcCtD
Dolasetron—Vertigo—Capecitabine—kidney cancer	0.000192	0.000607	CcSEcCtD
Dolasetron—Asthenia—Vincristine—kidney cancer	0.000192	0.000607	CcSEcCtD
Dolasetron—Syncope—Capecitabine—kidney cancer	0.000191	0.000606	CcSEcCtD
Dolasetron—Paraesthesia—Paclitaxel—kidney cancer	0.000191	0.000604	CcSEcCtD
Dolasetron—Dyspnoea—Paclitaxel—kidney cancer	0.000189	0.000599	CcSEcCtD
Dolasetron—Somnolence—Paclitaxel—kidney cancer	0.000189	0.000598	CcSEcCtD
Dolasetron—Palpitations—Capecitabine—kidney cancer	0.000189	0.000597	CcSEcCtD
Dolasetron—Rash—Dactinomycin—kidney cancer	0.000189	0.000597	CcSEcCtD
Dolasetron—Loss of consciousness—Capecitabine—kidney cancer	0.000188	0.000594	CcSEcCtD
Dolasetron—Dyspepsia—Paclitaxel—kidney cancer	0.000187	0.000592	CcSEcCtD
Dolasetron—Cough—Capecitabine—kidney cancer	0.000186	0.00059	CcSEcCtD
Dolasetron—Dysuria—Doxorubicin—kidney cancer	0.000185	0.000585	CcSEcCtD
Dolasetron—Decreased appetite—Paclitaxel—kidney cancer	0.000185	0.000584	CcSEcCtD
Dolasetron—Hypertension—Capecitabine—kidney cancer	0.000184	0.000584	CcSEcCtD
Dolasetron—Fatigue—Paclitaxel—kidney cancer	0.000183	0.00058	CcSEcCtD
Dolasetron—Diarrhoea—Vincristine—kidney cancer	0.000183	0.000579	CcSEcCtD
Dolasetron—Asthenia—Gemcitabine—kidney cancer	0.000182	0.000576	CcSEcCtD
Dolasetron—Arthralgia—Capecitabine—kidney cancer	0.000182	0.000576	CcSEcCtD
Dolasetron—Chest pain—Capecitabine—kidney cancer	0.000182	0.000576	CcSEcCtD
Dolasetron—Myalgia—Capecitabine—kidney cancer	0.000182	0.000576	CcSEcCtD
Dolasetron—Constipation—Paclitaxel—kidney cancer	0.000182	0.000575	CcSEcCtD
Dolasetron—Pain—Paclitaxel—kidney cancer	0.000182	0.000575	CcSEcCtD
Dolasetron—Anxiety—Capecitabine—kidney cancer	0.000181	0.000574	CcSEcCtD
Dolasetron—Discomfort—Capecitabine—kidney cancer	0.00018	0.000569	CcSEcCtD
Dolasetron—Pruritus—Gemcitabine—kidney cancer	0.000179	0.000568	CcSEcCtD
Dolasetron—Dry mouth—Capecitabine—kidney cancer	0.000178	0.000563	CcSEcCtD
Dolasetron—Pneumonia—Doxorubicin—kidney cancer	0.000177	0.000561	CcSEcCtD
Dolasetron—Dizziness—Vincristine—kidney cancer	0.000177	0.00056	CcSEcCtD
Dolasetron—Drowsiness—Doxorubicin—kidney cancer	0.000176	0.000558	CcSEcCtD
Dolasetron—Confusional state—Capecitabine—kidney cancer	0.000176	0.000556	CcSEcCtD
Dolasetron—Feeling abnormal—Paclitaxel—kidney cancer	0.000175	0.000554	CcSEcCtD
Dolasetron—Oedema—Capecitabine—kidney cancer	0.000174	0.000552	CcSEcCtD
Dolasetron—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000174	0.00055	CcSEcCtD
Dolasetron—Diarrhoea—Gemcitabine—kidney cancer	0.000174	0.000549	CcSEcCtD
Dolasetron—Stomatitis—Doxorubicin—kidney cancer	0.000172	0.000544	CcSEcCtD
Dolasetron—Jaundice—Doxorubicin—kidney cancer	0.000172	0.000544	CcSEcCtD
Dolasetron—Shock—Capecitabine—kidney cancer	0.000171	0.000543	CcSEcCtD
Dolasetron—Thrombocytopenia—Capecitabine—kidney cancer	0.000171	0.00054	CcSEcCtD
Dolasetron—Tachycardia—Capecitabine—kidney cancer	0.00017	0.000538	CcSEcCtD
Dolasetron—Urticaria—Paclitaxel—kidney cancer	0.000169	0.000534	CcSEcCtD
Dolasetron—Rash—Vincristine—kidney cancer	0.000169	0.000534	CcSEcCtD
Dolasetron—Hyperhidrosis—Capecitabine—kidney cancer	0.000168	0.000533	CcSEcCtD
Dolasetron—Dermatitis—Vincristine—kidney cancer	0.000168	0.000533	CcSEcCtD
Dolasetron—Haematuria—Doxorubicin—kidney cancer	0.000168	0.000532	CcSEcCtD
Dolasetron—Abdominal pain—Paclitaxel—kidney cancer	0.000168	0.000531	CcSEcCtD
Dolasetron—Body temperature increased—Paclitaxel—kidney cancer	0.000168	0.000531	CcSEcCtD
Dolasetron—Headache—Vincristine—kidney cancer	0.000167	0.00053	CcSEcCtD
Dolasetron—Epistaxis—Doxorubicin—kidney cancer	0.000166	0.000526	CcSEcCtD
Dolasetron—Anorexia—Capecitabine—kidney cancer	0.000166	0.000526	CcSEcCtD
Dolasetron—Hypotension—Capecitabine—kidney cancer	0.000163	0.000516	CcSEcCtD
Dolasetron—Bradycardia—Doxorubicin—kidney cancer	0.000161	0.00051	CcSEcCtD
Dolasetron—Rash—Gemcitabine—kidney cancer	0.00016	0.000506	CcSEcCtD
Dolasetron—Dermatitis—Gemcitabine—kidney cancer	0.00016	0.000506	CcSEcCtD
Dolasetron—Headache—Gemcitabine—kidney cancer	0.000159	0.000503	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000159	0.000503	CcSEcCtD
Dolasetron—Paraesthesia—Capecitabine—kidney cancer	0.000156	0.000495	CcSEcCtD
Dolasetron—Hypersensitivity—Paclitaxel—kidney cancer	0.000156	0.000495	CcSEcCtD
Dolasetron—Oedema peripheral—Doxorubicin—kidney cancer	0.000156	0.000493	CcSEcCtD
Dolasetron—Dyspnoea—Capecitabine—kidney cancer	0.000155	0.000492	CcSEcCtD
Dolasetron—Dyspepsia—Capecitabine—kidney cancer	0.000153	0.000486	CcSEcCtD
Dolasetron—Visual impairment—Doxorubicin—kidney cancer	0.000152	0.000482	CcSEcCtD
Dolasetron—Asthenia—Paclitaxel—kidney cancer	0.000152	0.000482	CcSEcCtD
Dolasetron—Decreased appetite—Capecitabine—kidney cancer	0.000151	0.00048	CcSEcCtD
Dolasetron—Fatigue—Capecitabine—kidney cancer	0.00015	0.000476	CcSEcCtD
Dolasetron—Pruritus—Paclitaxel—kidney cancer	0.00015	0.000476	CcSEcCtD
Dolasetron—Pain—Capecitabine—kidney cancer	0.000149	0.000472	CcSEcCtD
Dolasetron—Constipation—Capecitabine—kidney cancer	0.000149	0.000472	CcSEcCtD
Dolasetron—Tinnitus—Doxorubicin—kidney cancer	0.000147	0.000467	CcSEcCtD
Dolasetron—Flushing—Doxorubicin—kidney cancer	0.000147	0.000465	CcSEcCtD
Dolasetron—Diarrhoea—Paclitaxel—kidney cancer	0.000145	0.00046	CcSEcCtD
Dolasetron—Feeling abnormal—Capecitabine—kidney cancer	0.000144	0.000455	CcSEcCtD
Dolasetron—Gastrointestinal pain—Capecitabine—kidney cancer	0.000142	0.000451	CcSEcCtD
Dolasetron—Chills—Doxorubicin—kidney cancer	0.000142	0.000449	CcSEcCtD
Dolasetron—Arrhythmia—Doxorubicin—kidney cancer	0.000141	0.000447	CcSEcCtD
Dolasetron—Dizziness—Paclitaxel—kidney cancer	0.00014	0.000445	CcSEcCtD
Dolasetron—Urticaria—Capecitabine—kidney cancer	0.000138	0.000438	CcSEcCtD
Dolasetron—Abdominal pain—Capecitabine—kidney cancer	0.000138	0.000436	CcSEcCtD
Dolasetron—Body temperature increased—Capecitabine—kidney cancer	0.000138	0.000436	CcSEcCtD
Dolasetron—Flatulence—Doxorubicin—kidney cancer	0.000136	0.000429	CcSEcCtD
Dolasetron—Dysgeusia—Doxorubicin—kidney cancer	0.000135	0.000427	CcSEcCtD
Dolasetron—Rash—Paclitaxel—kidney cancer	0.000134	0.000424	CcSEcCtD
Dolasetron—Dermatitis—Paclitaxel—kidney cancer	0.000134	0.000424	CcSEcCtD
Dolasetron—Headache—Paclitaxel—kidney cancer	0.000133	0.000421	CcSEcCtD
Dolasetron—Hypersensitivity—Capecitabine—kidney cancer	0.000128	0.000406	CcSEcCtD
Dolasetron—Ill-defined disorder—Doxorubicin—kidney cancer	0.000128	0.000404	CcSEcCtD
Dolasetron—Anaemia—Doxorubicin—kidney cancer	0.000127	0.000403	CcSEcCtD
Dolasetron—Agitation—Doxorubicin—kidney cancer	0.000126	0.0004	CcSEcCtD
Dolasetron—Asthenia—Capecitabine—kidney cancer	0.000125	0.000396	CcSEcCtD
Dolasetron—Malaise—Doxorubicin—kidney cancer	0.000124	0.000393	CcSEcCtD
Dolasetron—Vertigo—Doxorubicin—kidney cancer	0.000124	0.000392	CcSEcCtD
Dolasetron—Syncope—Doxorubicin—kidney cancer	0.000123	0.000391	CcSEcCtD
Dolasetron—Pruritus—Capecitabine—kidney cancer	0.000123	0.00039	CcSEcCtD
Dolasetron—Palpitations—Doxorubicin—kidney cancer	0.000122	0.000385	CcSEcCtD
Dolasetron—Loss of consciousness—Doxorubicin—kidney cancer	0.000121	0.000383	CcSEcCtD
Dolasetron—Cough—Doxorubicin—kidney cancer	0.00012	0.00038	CcSEcCtD
Dolasetron—Convulsion—Doxorubicin—kidney cancer	0.000119	0.000378	CcSEcCtD
Dolasetron—Diarrhoea—Capecitabine—kidney cancer	0.000119	0.000378	CcSEcCtD
Dolasetron—Hypertension—Doxorubicin—kidney cancer	0.000119	0.000376	CcSEcCtD
Dolasetron—Myalgia—Doxorubicin—kidney cancer	0.000117	0.000371	CcSEcCtD
Dolasetron—Chest pain—Doxorubicin—kidney cancer	0.000117	0.000371	CcSEcCtD
Dolasetron—Arthralgia—Doxorubicin—kidney cancer	0.000117	0.000371	CcSEcCtD
Dolasetron—Anxiety—Doxorubicin—kidney cancer	0.000117	0.00037	CcSEcCtD
Dolasetron—Discomfort—Doxorubicin—kidney cancer	0.000116	0.000367	CcSEcCtD
Dolasetron—Dizziness—Capecitabine—kidney cancer	0.000115	0.000365	CcSEcCtD
Dolasetron—Dry mouth—Doxorubicin—kidney cancer	0.000115	0.000363	CcSEcCtD
Dolasetron—Confusional state—Doxorubicin—kidney cancer	0.000113	0.000359	CcSEcCtD
Dolasetron—Anaphylactic shock—Doxorubicin—kidney cancer	0.000112	0.000356	CcSEcCtD
Dolasetron—Oedema—Doxorubicin—kidney cancer	0.000112	0.000356	CcSEcCtD
Dolasetron—Shock—Doxorubicin—kidney cancer	0.000111	0.00035	CcSEcCtD
Dolasetron—Thrombocytopenia—Doxorubicin—kidney cancer	0.00011	0.000348	CcSEcCtD
Dolasetron—Rash—Capecitabine—kidney cancer	0.00011	0.000348	CcSEcCtD
Dolasetron—Dermatitis—Capecitabine—kidney cancer	0.00011	0.000348	CcSEcCtD
Dolasetron—Tachycardia—Doxorubicin—kidney cancer	0.00011	0.000347	CcSEcCtD
Dolasetron—Headache—Capecitabine—kidney cancer	0.000109	0.000346	CcSEcCtD
Dolasetron—Hyperhidrosis—Doxorubicin—kidney cancer	0.000109	0.000344	CcSEcCtD
Dolasetron—Anorexia—Doxorubicin—kidney cancer	0.000107	0.000339	CcSEcCtD
Dolasetron—Hypotension—Doxorubicin—kidney cancer	0.000105	0.000332	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000102	0.000324	CcSEcCtD
Dolasetron—Paraesthesia—Doxorubicin—kidney cancer	0.000101	0.000319	CcSEcCtD
Dolasetron—Dyspnoea—Doxorubicin—kidney cancer	0.0001	0.000317	CcSEcCtD
Dolasetron—Somnolence—Doxorubicin—kidney cancer	9.99e-05	0.000316	CcSEcCtD
Dolasetron—Dyspepsia—Doxorubicin—kidney cancer	9.89e-05	0.000313	CcSEcCtD
Dolasetron—Decreased appetite—Doxorubicin—kidney cancer	9.76e-05	0.000309	CcSEcCtD
Dolasetron—Fatigue—Doxorubicin—kidney cancer	9.68e-05	0.000307	CcSEcCtD
Dolasetron—Pain—Doxorubicin—kidney cancer	9.61e-05	0.000304	CcSEcCtD
Dolasetron—Constipation—Doxorubicin—kidney cancer	9.61e-05	0.000304	CcSEcCtD
Dolasetron—Feeling abnormal—Doxorubicin—kidney cancer	9.26e-05	0.000293	CcSEcCtD
Dolasetron—Gastrointestinal pain—Doxorubicin—kidney cancer	9.19e-05	0.000291	CcSEcCtD
Dolasetron—Urticaria—Doxorubicin—kidney cancer	8.92e-05	0.000283	CcSEcCtD
Dolasetron—Abdominal pain—Doxorubicin—kidney cancer	8.88e-05	0.000281	CcSEcCtD
Dolasetron—Body temperature increased—Doxorubicin—kidney cancer	8.88e-05	0.000281	CcSEcCtD
Dolasetron—Hypersensitivity—Doxorubicin—kidney cancer	8.28e-05	0.000262	CcSEcCtD
Dolasetron—Asthenia—Doxorubicin—kidney cancer	8.06e-05	0.000255	CcSEcCtD
Dolasetron—Pruritus—Doxorubicin—kidney cancer	7.95e-05	0.000252	CcSEcCtD
Dolasetron—Diarrhoea—Doxorubicin—kidney cancer	7.69e-05	0.000243	CcSEcCtD
Dolasetron—Dizziness—Doxorubicin—kidney cancer	7.43e-05	0.000235	CcSEcCtD
Dolasetron—Rash—Doxorubicin—kidney cancer	7.08e-05	0.000224	CcSEcCtD
Dolasetron—Dermatitis—Doxorubicin—kidney cancer	7.08e-05	0.000224	CcSEcCtD
Dolasetron—Headache—Doxorubicin—kidney cancer	7.04e-05	0.000223	CcSEcCtD
